Polarization of TAMs towards the M2 phenotype within the tumor microenvironment can reduce the number of CD8+ T cells involved in specific antitumor effects by engaging the PD-1/PD-L1 pathway, thereby increasing the likelihood of tumor immune evasion. This evidence concerns the gene CD8A and neoplasm.